These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7562480)

  • 1. Blood pressure (BP) and renal vasoconstrictor responses to acute blockade of nitric oxide: persistence of renal vasoconstriction despite normalization of BP with either verapamil or sodium nitroprusside.
    Baylis C; Masilamani S; Losonczy G; Samsell L; Harton P; Engels K
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1135-41. PubMed ID: 7562480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis inhibition are independent of the sympathetic nervous system and angiotensin II.
    Baylis C; Harvey J; Santmyire BR; Engels K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):693-8. PubMed ID: 9918577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of nitric oxide in the modulation of the vascular response to angiotensin II in hypertensive rats].
    Sánchez Mendoza A; Vázquez Cruz B; Escalante Acosta BA
    Arch Inst Cardiol Mex; 1996; 66(4):306-12. PubMed ID: 8984951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of nitric oxide inhibition on blood pressure depends on rat strain.
    Forster J; Beebe P; Wang H; Wood JG
    J Surg Res; 2001 Apr; 96(2):218-23. PubMed ID: 11266276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
    Moreau P; Takase H; Küng CF; Lüscher TF
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats.
    Gardiner SM; March JE; Kemp PA; Bennett T
    Br J Pharmacol; 1998 May; 124(2):299-306. PubMed ID: 9641546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of the existence of nitric oxide-independent as well as nitric oxide-dependent vasodilator mechanisms in the in situ renal circulation in near term pregnant rats.
    Chu ZM; Beilin LJ
    Br J Pharmacol; 1997 Sep; 122(2):307-15. PubMed ID: 9313940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels.
    Dursun N; Arifoglu C; Süer C; Keskinol L
    Biol Trace Elem Res; 2005 May; 104(2):141-9. PubMed ID: 15894814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    Hajj-Ali AF; Reilly TM; Wong PC
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?
    Mathie RT; Ralevic V; Moore KP; Burnstock G
    Hepatology; 1996 Jan; 23(1):130-6. PubMed ID: 8550032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead exposure effect on angiotensin II renal vasoconstriction.
    Robles HV; Romo E; Sanchez-Mendoza A; Rios A; Soto V; Avila-Casado MC; Medina A; Escalante B
    Hum Exp Toxicol; 2007 Jun; 26(6):499-507. PubMed ID: 17698945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic nitric oxide inhibition on the renal excretory response to leptin.
    Villarreal D; Reams G; Samar H; Spear R; Freeman RH
    Obes Res; 2004 Jun; 12(6):1006-10. PubMed ID: 15229341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
    Demeilliers B; Mimran A; Jover B
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats.
    Moreno JM; Wangensteen R; Sainz J; Rodríguez-Gomez I; Chamorro V; Osuna A; Vargas F
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E182-8. PubMed ID: 12657567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.